APA (7th ed.) Citation

CW, H., P, K., KR, D., DC, M., D, T., N, S., . . . SJ, S. (2025). Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis. Alimentary pharmacology & therapeutics, 61(5), 835. https://doi.org/10.1111/apt.18458

Chicago Style (17th ed.) Citation

CW, Howden, Katz P, DeVault KR, Metz DC, Tamene D, Smith N, Hunt B, Chang YM, and Spechler SJ. "Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis." Alimentary Pharmacology & Therapeutics 61, no. 5 (2025): 835. https://doi.org/10.1111/apt.18458.

MLA (9th ed.) Citation

CW, Howden, et al. "Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis." Alimentary Pharmacology & Therapeutics, vol. 61, no. 5, 2025, p. 835, https://doi.org/10.1111/apt.18458.